Almac Clinical Technologies Releases New Podcast Series Entitled “Spotlight on IRT: Best Practices”
July 25, 2018
Souderton, PA – 25 July 2018 – Almac Clinical Technologies, a global leader in technology-enabled solutions for managing clinical trial patient and supplies data through its flagship IXRS® 3 Interactive Response Technology (IRT) debuts a first-in-industry podcast series entitled, “Spotlight on IRT: Best Practices.”
This podcast features both Almac thought leaders and outside experts discussing best practices relating to IRT, protocol changes, regulatory audits and the most current innovations in order to improve costs, safety and efficiencies in today’s complex clinical trials. The podcast homepage resides on the resource-filled Almac Clinical University and offers the listener the opportunity to submit questions, comments and/or a speaker for future episodes.
“Almac Clinical Technologies has been the leading partner in providing solutions and solving the challenges that occur in today’s dynamic global clinical trial landscape. Too often we see clients relying on legacy processes out of familiarity and forget to consider alternatives that may prove to be more efficient ways to approach a problem. Our intent is to shed light on some of the problem areas we see our clients facing on a regular basis, and suggest proactive and holistic solutions which can be readily implemented to ensure continued success,” said Valarie Higgins, President and Managing Director of Almac Clinical Technologies.
Matt Lowrie, Almac Clinical Technologies’ Quality Assurance Group Manager, who has 15+ years of hosting and managing regulatory agency inspections and effectively answering demands for hundreds of trials, serves as host for the series. The “Spotlight on IRT: Best Practices” podcast is free to access, available on iTunes®, Google Play™ and all other available podcast applications. Amazon Echo owners can also enable access to the podcast through the Almac Podcast skill, then simply asking Alexa to “Play Almac Podcast.”
To learn more about how Almac Clinical Technologies can help to transform your clinical trial, please visit almacgroup.com/clinical-technologies
About Almac Group
‘Partnering to Advance Human Health’
The Almac Group is an established contract development and manufacturing organization that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialization, API manufacture, formulation development, clinical trial supply, Interactive Response Technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organization that has organically grown over almost 50 years and now employs close to 5600 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in Europe, the US (Pennsylvania, North Carolina and California) and Asia (Singapore and Tokyo)